Literature DB >> 18568509

Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy.

Christophe Le Tourneau1, Guy-Michel Jung, Christian Borel, Guy Bronner, Henri Flesch, Michel Velten.   

Abstract

CONCLUSIONS: Given that radiation therapy (RT) is currently initiated as soon as possible after surgery, our results indicate that the main prognostic factors of survival are pT and pN stages in patients treated with surgery and postoperative RT for locally advanced head and neck squamous cell carcinoma (HNSCC).
OBJECTIVES: To determine the prognostic factors for survival in patients treated with surgery and postoperative RT for locally advanced HNSCC. PATIENTS AND METHODS: A retrospective study was performed on 308 consecutive patients treated from 1990 to 1998 with surgery and postoperative RT. In addition to histological factors, time-related factors were considered.
RESULTS: The median age of the whole cohort was 56 years (range 35-83). Median follow-up was 98 months. Median interval from surgery to the start of RT was 44 days (range 18-157), while median RT duration was 52 days (range 22-115). From univariate analysis of overall survival, statistically significant prognostic factors were pT stage (p<0.0001), pN stage (p=0.008), RT duration (p=0.01) and total treatment time (p=0.02). Perineural invasion, perivascular invasion, extranodal spread and positive resection margins did not appear to be related to survival. From multivariate analysis, the only statistically independent prognostic factors appeared to be pT and pN stages.

Entities:  

Mesh:

Year:  2008        PMID: 18568509     DOI: 10.1080/00016480701675668

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  12 in total

1.  [Laryngectomy-still state of the art?]

Authors:  J M Vahl; P J Schuler; J Greve; S Laban; A Knopf; T K Hoffmann
Journal:  HNO       Date:  2019-12       Impact factor: 1.284

2.  The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.

Authors:  W J Pattje; E Schuuring; M F Mastik; L Slagter-Menkema; M L Schrijvers; S Alessi; B F A M van der Laan; J L N Roodenburg; J A Langendijk; J E van der Wal
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

3.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Authors:  Chi-Chih Lai; Pai-Mei Lin; Sheng-Fung Lin; Cheng-Hsien Hsu; Hsin-Ching Lin; Ming-Luen Hu; Cheng-Ming Hsu; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2013-03-12

4.  Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.

Authors:  Kyu-Ho Choi; Ie Ryung Yoo; Eun Ji Han; Yeon Sil Kim; Gi Won Kim; Sae Jung Na; Dong-Il Sun; So Lyung Jung; Chan-Kwon Jung; Min-Sik Kim; So-Yeon Lee; Sung Hoon Kim
Journal:  Nucl Med Mol Imaging       Date:  2010-11-16

Review 5.  Molecular pathways: not a simple tube--the many functions of blood vessels.

Authors:  Brent A Orr; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2014-07-29       Impact factor: 12.531

6.  Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer.

Authors:  Jeremy P Harris; Michelle M Chen; Ryan K Orosco; Davud Sirjani; Vasu Divi; Wendy Hara
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

7.  DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.

Authors:  Zhen Shen; Wanli Ren; Yanxia Bai; Zhengshuai Chen; Jingjie Li; Bin Li; Tianbo Jin; Peilong Cao; Yuan Shao
Journal:  Oncotarget       Date:  2016-11-29

8.  Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma.

Authors:  Li-Yu Lee; Dante De Paz; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Chia-Hsun Hsieh; Li-Ang Lee; Tzu-Chen Yen; Chun-Ta Liao; Ching-Hua Yeh; Chung-Jan Kang
Journal:  Cancer Med       Date:  2019-07-10       Impact factor: 4.452

9.  Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival.

Authors:  Kambiz Novin; Ahmad Ameri; Saba Faraji; Peyman Torbati; Nafiseh Mortazavi
Journal:  Iran J Cancer Prev       Date:  2015-10-27

10.  Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma.

Authors:  Clara Backes; Henning Bier; Andreas Knopf
Journal:  Oncotarget       Date:  2017-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.